Dotmatics
ResourcesChatSaved
Featured image

...

Dotmatics Introduces Enhanced User Interface and Simplified Navigation to its ELN and Data Discovery Platform

Key Takeaways

  • Content analysis available
  • Original source preserved
  • Mobile-optimized display
Show less
1 min read

New features include Process Capture, Enhanced Biological Sequence Visualization, an Integration Framework, New Table Control, and a new Configuration Management Hub

Enhanced User Experience and Interface

The primary focus of the 7.1 release is a significant overhaul of the UI and user experience (UX). After close collaboration with customers, Dotmatics simplified the navigation across and within modules, creating a cleaner and more intuitive experience. The UI refresh greatly simplifies the experience for all users with consistent UX patterns used throughout. As part of the new navigation interface, users can easily navigate between two primary actions: data in (ELN) or data out (Data Discovery browser).

The UI updates not only enhance user experience, but enable faster and more efficient work, which leads to increased productivity and a smoother workflow.

"We’ve listened closely to our users, and Dotmatics ELN and Data Discovery Platform 7.1 gives them a more intuitive and cohesive experience that they are looking for,” said Kalim Saliba, chief product officer at Dotmatics. “These improvements are designed to streamline workflows and significantly boost productivity of scientists in the lab.”

New Features and Functionality

Version 7.1 introduces a collection of new features and functionality designed to enhance research and development capabilities across various domains:

  • Formulated Product Research Support
    New capabilities to support R&D of formulated products will benefit both Chemicals & Materials and Life Sciences customers. The Process Design capability offers a rich interface for automatically enumerating formulations based on defined process variance, selecting those to test, and tracking experimental outcomes. The introduction of Multi-Experiment Workflows provides a graphical interface to visually connect outputs from experiments to the inputs of other downstream experiments. This provides a visual way to manage and capture the full flow of data within the network, from experiment to experiment.

  • Integration Framework: Version 7.1 includes an Integration Framework utilizing the industry-leading Apache NiFi tool, enabling powerful connections to external APIs and applications, both within the Dotmatics family and third-party systems. This streamlines communication and data exchange, enhancing interoperability by standardizing API-driven traffic in a robust fashion.

  • Enhanced Biological Sequence Visualization
    Leveraging the visualization library of Dotmatics Geneious, the new sequence visualization capability in Data Discovery aligns with industry-leading biology tools. This provides users with consistent visuals and actions across different stages of their workflows, enhancing the analysis and interpretation of biological data.

  • New Table Control
    The new Table Control leverages an industry-leading React component to provide rich, Excel-like functionality for managing and manipulating data. Initially appearing in ELN Canvas forms, this feature will replace legacy grids, marking the first stage of a multi-phase initiative to deliver state-of-the-art table functionality across the platform.

  • Configuration Management Hub
    The new Configuration Management Hub (CMH) in version 7.1 provides the foundations for comprehensive management and staging of platform configurations. Initially supporting the management of configurations for the new Inventory capability, CMH will be progressively extended in future releases.

  • 7.1 Integrations with Luma
    Users will find enhanced integration with Luma Lab Connect, allowing instrument data to be associated with ELN experiments and accessed via Data Discovery queries. The Integration Framework facilitates seamless data exchange via RESTful APIs, with additional interactions planned for future updates.

The enhancements to Dotmatics ELN and Data Discovery Platform 7.1 collectively elevate the user experience, reduce administrative burdens, and decrease the time required to use the platform. Customers will be able to work more efficiently, and make more informed decisions based on comprehensive datasets. Customers can expect 7.1 to be available during the coming weeks.

Forward Looking Statements

This press release contains forward-looking statements that are intended to outline our general product strategy. It is intended for informational purposes only and speaks only as of the date the statements are first published. It is not a commitment to deliver any functionality and should not be relied upon for making purchase decisions. You should not put any contractual reliance on these statements. The development, release, and timing of any products or capabilities remains at the sole discretion of Dotmatics.

No representation or warranty, express or implied, is provided in relation to the fairness, accuracy, correctness, completeness or reliability of the information, opinions or conclusions expressed herein. Only those representations or warranties that are made in or pursuant to one or more definitive agreements involving the parties will have any legal effect.

About Dotmatics

Dotmatics is a leader in R&D scientific software connecting science, data, and decision-making. Its enterprise R&D platform and scientists’ favorite applications drive efficiency and accelerate innovation. More than 2 million scientists and 10,000 customers trust Dotmatics to help them create a healthier, cleaner, safer world. Dotmatics is a global team of more than 800 people dedicated to supporting its customers in over 180 countries. The company’s principal office is in Boston, with 14 offices and R&D teams located around the world.

Dotmatics is backed by Insight Partners, a leading global venture capital and private equity firm investing in high-growth technology and software scaleup companies. Learn more about Dotmatics, its platform, and applications including GraphPad Prism, Geneious, SnapGene, Protein Metrics, and LabArchives at https://www.dotmatics.com.

Media Contact

Cory Edwards
Vice President, Corporate Communications
Dotmatics
media@dotmatics.com

https://www.dotmatics.com/news/eln-and-data-discovery-platform-7-1
Play

Dotmatics Introduces Enhanced User Interface

Related To Biology Discovery
[Demand] Biology Solution Overview
[Demand] Biology Solution Overview
TOUR
Luma Platform Overview
Luma Platform Overview
DOCUMENT
Scalable Integrations
Scalable Integrations
VIDEO
Data Analysis & Visualization - Tour Video (Bio)
Data Analysis & Visualization - Tour Video (Bio)
TOUR
Biotech Overview
Biotech Overview
VIDEO
Content For Bench Scientists
Integrated ELN - Tour Video (Chem)
Integrated ELN - Tour Video (Chem)
TOUR
Luma_ C&M Anonymized Case Study
Luma_ C&M Anonymized Case Study
DOCUMENT
Early Stage Biotech Customer Stories
Early Stage Biotech Customer Stories
VIDEO
[Demand] Chemistry Solution Overview
[Demand] Chemistry Solution Overview
TOUR
ET: Chemical Synthesis Documentation in ELN
ET: Chemical Synthesis Documentation in ELN
TOUR
Content For Chemicals & Materials
[Demand] C&M Solution Overview
[Demand] C&M Solution Overview
TOUR
MD: Data Analysis & Visualisation - Vortex SAR Analysis
MD: Data Analysis & Visualisation - Vortex SAR Analysis
TOUR
Why Dotmatics?
Why Dotmatics?
VIDEO
[WEB] MD: Luma - Flow Cytometry Use Case (IT Persona)
[WEB] MD: Luma - Flow Cytometry Use Case (IT Persona)
TOUR
Luma-Summit-CreatePlotWithJoin
Luma-Summit-CreatePlotWithJoin
TOUR
Similar to Dotmatics Introduces Enhanced User Interface
Luma-Summit-Create-Table1
Luma-Summit-Create-Table1
TOUR
Luma-Summit-Add-Filters
Luma-Summit-Add-Filters
TOUR
Value of Dotmatics to Early Stage Biotech
Value of Dotmatics to Early Stage Biotech
VIDEO
Assay Data Management - Tour Video (Bio)
Assay Data Management - Tour Video (Bio)
TOUR
[WEB] Bio - Assay Data Management (Dose Response)
[WEB] Bio - Assay Data Management (Dose Response)
TOUR
Newest Content
How we approach early-stage biotech challenges
How we approach early-stage biotech challenges
VIDEO
Powered by Navless.ai